153 related articles for article (PubMed ID: 28273554)
1. Head drop after botox: Electrodiagnostic evaluation of iatrogenic botulinum toxicity.
Szuch E; Caress JB; Paudyal B; Brashear A; Cartwright MS; Strowd RE
Clin Neurol Neurosurg; 2017 May; 156():1-3. PubMed ID: 28273554
[TBL] [Abstract][Full Text] [Related]
2. Contralateral weakness following botulinum toxin for poststroke spasticity.
Thomas AM; Simpson DM
Muscle Nerve; 2012 Sep; 46(3):443-8. PubMed ID: 22907238
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological abnormalities of the neuromuscular transmission in two patients with botulism-like syndrome following Botulinum-A muscle injections.
Theuriet J; Huchon L; Luaute J; Vallet AE; Bouhour F; Pegat A
Neurophysiol Clin; 2024 Jul; 54(4):102984. PubMed ID: 38759365
[TBL] [Abstract][Full Text] [Related]
4. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
Fan KL; Wang YL; Chu G; Leung LP
J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
[TBL] [Abstract][Full Text] [Related]
5. Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity.
Camões-Barbosa A; Ribeiro IM; Medeiros L
Acta Med Port; 2020 Nov; 33(11):761-764. PubMed ID: 31759399
[TBL] [Abstract][Full Text] [Related]
6. Iatrogenic Botulism Outbreak in Egypt due to a Counterfeit Botulinum Toxin A Preparation - A Descriptive Series of Patient Features and Outcome.
Rashid EAMA; El-Mahdy NM; Kharoub HS; Gouda AS; ElNabarawy NA; Mégarbane B
Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):622-627. PubMed ID: 29786953
[TBL] [Abstract][Full Text] [Related]
7. Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis.
Iwase T; Iwase C
Graefes Arch Clin Exp Ophthalmol; 2006 Mar; 244(3):415-6. PubMed ID: 16175373
[No Abstract] [Full Text] [Related]
8. Relapsing-remitting severe generalized muscular weakness after botulinum toxin treatment for hyperhidrosis.
Chiarello D; Piombo M; Corbetto M; Di Pino G; Assenza G; Capone F; Di Lazzaro V
Muscle Nerve; 2014 Sep; 50(3):456-7. PubMed ID: 24890202
[No Abstract] [Full Text] [Related]
9. Electrophysiological abnormalities in iatrogenic botulism: Two case reports and review of the literature.
Leonardi L; Haggiag S; Petrucci A; Lispi L
J Clin Neurosci; 2019 Feb; 60():138-141. PubMed ID: 30348587
[TBL] [Abstract][Full Text] [Related]
10. Iatrogenic systemic botulism after intragastric botulinum neurotoxin injection: Case report.
Kılboz BB; Ervatan Z; Dumlu R; Akan O
Eur J Neurol; 2023 Oct; 30(10):3394-3396. PubMed ID: 37505930
[TBL] [Abstract][Full Text] [Related]
11. Single-fiber electromyography analysis of botulinum toxin diffusion in patients with fatigue and pseudobotulism.
Ruet A; Durand MC; Denys P; Lofaso F; Genet F; Schnitzler A
Arch Phys Med Rehabil; 2015 Jun; 96(6):1103-9. PubMed ID: 25620718
[TBL] [Abstract][Full Text] [Related]
12. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A therapy for cervical dystonia.
Castelão M; Marques RE; Duarte GS; Rodrigues FB; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003633. PubMed ID: 29230798
[TBL] [Abstract][Full Text] [Related]
14. Pilot study evaluating the safety of intradetrusor injections of botulinum toxin type A: investigation of generalized spread using single-fiber EMG.
Schnitzler A; Genet F; Durand MC; Roche N; Bensmail D; Chartier-Kastler E; Denys P
Neurourol Urodyn; 2011 Nov; 30(8):1533-7. PubMed ID: 21661038
[TBL] [Abstract][Full Text] [Related]
15. Generalized neurological symptoms following treatment of focal hyperhidrosis with botulinum toxin A.
Kouris A; Agiasofitou E; Gregoriou S; Sofouri E; Kontochristopoulos G; Panagopoulos G
Int J Dermatol; 2014 Nov; 53(11):e544-7. PubMed ID: 25209010
[No Abstract] [Full Text] [Related]
16. Iatrogenic botulism in an amateur weight-lifter.
Duffey P; Brown C
Mov Disord; 2006 Jul; 21(7):1056. PubMed ID: 16639740
[No Abstract] [Full Text] [Related]
17. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
[TBL] [Abstract][Full Text] [Related]
18. Cervical Kyphotic Deformity Worsening After Extensor Cervical Muscle Paralysis from Botulinum Toxin Injection.
Agyei JO; Smolar DE; Hartke J; Fanous AA; Gibbons KJ
World Neurosurg; 2019 May; 125():409-413. PubMed ID: 30822591
[TBL] [Abstract][Full Text] [Related]
19. In vivo study of paraspinal muscle weakness using botulinum toxin in one primate model.
Han SK; Lee Y; Hong JJ; Yeo HG; Seo J; Jeon CY; Jeong KJ; Jin YB; Kang P; Lee S; Shin CS; Kim YE; Chun KJ; Chang KT; Lee SR
Clin Biomech (Bristol, Avon); 2018 Mar; 53():1-6. PubMed ID: 29407350
[TBL] [Abstract][Full Text] [Related]
20. Iatrogenic botulism after the therapeutic use of botulinum toxin-A: a case report and review of the literature.
Ghasemi M; Norouzi R; Salari M; Asadi B
Clin Neuropharmacol; 2012; 35(5):254-7. PubMed ID: 22986799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
